Ulcerative Colitis

One of the deadliest and rarest forms of cancer is the focus of a Phase III study initiated by Eli Lilly (NYSE:LLY) and Company recently.

Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products.

Merck & Co., Inc.

(NYSE:MRK) and Paratek Pharmaceuticals, Inc.

announced recently that Paratek has entered into an exclusive, worldwide collaborative development and license agreement with Merck -through an affiliate - for PTK 0796, a novel, broad-spectrum aminomethylcycline (AMC) antibiotic with oral and intravenous (IV) formulations currently in Phase I clinical testing.

About Financial News USA Financial News USA is a Next Generation Financial Communications firm focused on the distribution of market moving news.

Financial News USA has developed leading edge e-publishing tools including programming proprietary RSS feeds and enabling open source press release publishing across its network.

Financial News USA has been agg...

Read more...